long-acting interferon drug product company in Hepatitis and Cytokines
Home / Product Category / Reagents / Growth Factors / Human Flt-3 Ligand (rHuFlt3-L)

loading

Human Flt-3 Ligand (rHuFlt3-L) Human Flt-3 Ligand (rHuFlt3-L)

loading

Human Flt-3 Ligand (rHuFlt3-L)

Availability:
Quantity:
 
 
  • SJA07

  • 50μg

Specifications and Use

Description:

Flt3-L is a growth factor that regulates proliferation of early hematopoietic cells. Flt3-L binds to cells expressing the tyrosine kinase receptor Flt3. By itself, Flt3-L does not stimulate proliferation of early hematopoietic cells. Instead, it synergizes with other colony-stimulating factors (CSFs) and interleukins to induce growth and differentiation.

Source: Insect cell (High Five).

Molecular Mass: Theoretical molecular mass is about 19.1 kD.

Purity: ≥97%.

Endotoxin Level: <1EU/µg, determined by the LAL method.

Biological Activity:

Measured in a cell proliferation assay using M1. The specific Activity shall be not less than 1.2 x106 U/mg

Formulation:

Lyophilized from a 0.2μm filtered solution in 50mM NaAc, 50 mM NaCl, pH4.0.

Reconstitution:

It is recommended to centrifuge at 10,000rpm for 30-60 sec or 3000rpm for 5 min before opening the tube, and then reconstitute with 0.2ml sterile water.

Storage:

  • Lyophilized samples are stable for 12 months from date of manufacture at -20℃ to -70℃. The relevant stability study is in progress, and the expiry date would be updated once the stability study is finished.

  • Upon reconstitution, this cytokine can be stored under sterile conditions at 2- 8℃ for one month or at -20℃ to -70℃ in a manual defrost freezer for three months without detectable loss of activity.

  • Avoid repeated freeze-thaw cycles.


For Laboratory Use Only.


facebook sharing button
twitter sharing button
line sharing button
wechat sharing button
linkedin sharing button
pinterest sharing button
whatsapp sharing button
sharethis sharing button
Previous: 
Next: 

Related News

content is empty!

Facebook
Twitter
LinkedIn
Instagram

WELCOME

Specialized in R&D and production of recombinant protein drugs, and committed to providing better solutions for viral hepatitis, malignant tumor and immunotherapy etc..
Leave a Message
Get In Touch